Nanobiotix SA (NBTX)
3.49
+0.16
(+4.80%)
USD |
NASDAQ |
Dec 16, 16:00
3.48
-0.01
(-0.29%)
After-Hours: 20:00
Nanobiotix Total Liabilities (Quarterly): 116.25M for June 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 39.02M |
| Cellectis SA | 266.45M |
| Genfit SA | 117.09M |
| Innate Pharma SA | 131.52M |
| Inventiva SA | 127.00M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 92.91M |
| Shareholders Equity (Quarterly) | -23.34M |
| Debt to Equity Ratio | -2.043 |
| Current Ratio | 1.424 |
| Net Debt Paydown Yield | 0.48% |